Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Gulf J Oncolog ; 1(32): 71-87, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32342923

RESUMO

With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there has been significant investment from the government and private health care providers to enhance the quality of cancer care in the UAE. The UAE is a developing country with solid economic resources that can be utilized to improve cancer care across the country. There is limited data regarding the incidence, survival, and potential risk factors for cancer in the UAE. The UAE Oncology Task Force was established in 2019 by cancer care providers from across the UAE under the auspices of Emirates Oncology Society. In this paper we summarize the history of cancer care in the UAE, report the national cancer incidence, and outline current challenges and opportunities to enhance and standardize cancer care. We provide recommendations for policymakers and the UAE Oncology community for the delivery of high-quality cancer care. These recommendations are aligned with the UAE government's vision to reduce cancer mortality and provide high quality healthcare for its citizens.


Assuntos
Neoplasias/epidemiologia , História do Século XXI , Humanos , Emirados Árabes Unidos
2.
Nephrology (Carlton) ; 8(3): 139-41, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15012730

RESUMO

Renal water handling is regulated by the release of arginine vasopressin (AVP) and the subsequent insertion of aquaporin 2 (AQP2) in the apical membrane of collecting duct cells. This in turn increases the membrane permeability to water and the passive reabsorption of water down the concentration gradient present in the medulla. Aquaporin 2 can be detected in the urine under conditions of antidiuresis. We wish to validate an assay for urinary AQP2. Fourteen volunteers participated in studies of water loading and water deprivation followed by the administration of 1-deamino-8-D-arginine vasopressin (dDAVP). Urine osmolality was measured by vapour pressure osmometry. Urinary AQP2 was measured by using a chemiluminescent assay. Baseline correlations between serum AVP levels, urinary osmolality and urinary AQP2 levels were not significant. Following the administration of dDAVP, a positive correlation between urine osmolality and urinary AQP2 was evident (r = 0.762). For specific conditions where renal water retention is stimulated via AVP, urinary AQP2 measurements provide a reproducible measurement of the renal actions of AVP.


Assuntos
Aquaporina 2/urina , Desamino Arginina Vasopressina/farmacologia , Ingestão de Líquidos , Rim/efeitos dos fármacos , Medições Luminescentes , Urinálise/métodos , Privação de Água , Administração Intranasal , Adulto , Arginina Vasopressina/sangue , Desamino Arginina Vasopressina/administração & dosagem , Feminino , Humanos , Rim/metabolismo , Capacidade de Concentração Renal/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Concentração Osmolar , Valores de Referência , Reprodutibilidade dos Testes , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA